Company intelligence / Profile preview

Solara Holdings

Chennai, Tamil Nadu, India

Ownership: Private
Employees: ~2085
Development stage: Other

Overview

Solara Active Pharma Sciences manufactures commercial APIs sold globally. It supplies APIs for numerous indications, regularly launches new products, and is expanding its contract manufacturing services. Recent strategic changes focus on cost optimization and diversification away from commodity APIs. The company reported a return to profitability with improved gross margins in the last 1–2 years but continues to face growth challenges in line with industry headwinds.

Therapeutic areas: CardiovascularImmunologyEndocrinologyRheumatologyPulmonologyInfectious DiseasesNeurologyGastroenterologyOtherDermatologyPsychiatry
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

TPG GrowthNumerous global pharma customers for APIs and CRAMS (names not publicly disclosed)

Beyond the preview

Go deeper on Solara Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solara Holdings.

Explore the full profile